In vitro-deranged intestinal immune response to gliadin in type 1 diabetes
- PMID: 15220190
- DOI: 10.2337/diabetes.53.7.1680
In vitro-deranged intestinal immune response to gliadin in type 1 diabetes
Abstract
Dietary gluten has been associated with an increased risk of type 1 diabetes. We have evaluated inflammation and the mucosal immune response to gliadin in the jejunum of patients with type 1 diabetes. Small intestinal biopsies from 17 children with type 1 diabetes without serological markers of celiac disease and from 50 age-matched control subjects were examined by immunohistochemistry. In addition, biopsies from 12 type 1 diabetic patients and 8 control subjects were cultured with gliadin or ovalbumin peptic-tryptic digest and examined for epithelial infiltration and lamina propria T-cell activation. The density of intraepithelial CD3(+) and gammadelta(+) cells and of lamina propria CD25(+) mononuclear cells was higher in jejunal biopsies from type 1 diabetic patients versus control subjects. In the patients' biopsies cultured with peptic-tryptic gliadin, there was epithelial infiltration by CD3(+) cells, a significant increase in lamina propria CD25(+) and CD80(+) cells and enhanced expression of lamina propria CD54 and crypt HLA-DR. No such phenomena were observed in control subjects, even those with celiac disease-associated HLA haplotypes. In conclusion, signs of mucosal inflammation were present in jejunal biopsies from type 1 diabetic patients, and organ culture studies indicate a deranged mucosal immune response to gliadin.
Similar articles
-
An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.Gut. 2003 Jan;52(1):57-62. doi: 10.1136/gut.52.1.57. Gut. 2003. PMID: 12477760 Free PMC article.
-
Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus.Am J Gastroenterol. 2003 Mar;98(3):590-5. doi: 10.1111/j.1572-0241.2003.07301.x. Am J Gastroenterol. 2003. PMID: 12650792
-
Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa.Am J Gastroenterol. 2005 Oct;100(10):2294-8. doi: 10.1111/j.1572-0241.2005.41134.x. Am J Gastroenterol. 2005. PMID: 16181383
-
In vitro model of the pathogenesis of celiac disease.Dig Dis. 1998 Nov-Dec;16(6):341-4. doi: 10.1159/000016888. Dig Dis. 1998. PMID: 10207219 Review.
-
Intestinal immunity and type 1 diabetes.J Pediatr Gastroenterol Nutr. 2004 Jun;39 Suppl 3:S732-3. doi: 10.1097/00005176-200406003-00008. J Pediatr Gastroenterol Nutr. 2004. PMID: 15167365 Review. No abstract available.
Cited by
-
Serological markers of intestinal barrier impairment do not correlate with duration of diabetes and glycated hemoglobin in adult patients with type 1 and type 2 diabetes mellitus.Physiol Res. 2022 Aug 4;71(3):357-368. doi: 10.33549/physiolres.934874. Epub 2022 May 26. Physiol Res. 2022. PMID: 35616045 Free PMC article.
-
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.Front Immunol. 2021 Jun 3;12:653560. doi: 10.3389/fimmu.2021.653560. eCollection 2021. Front Immunol. 2021. PMID: 34149694 Free PMC article. Review.
-
Early Nutrition and Risk of Type 1 Diabetes: The Role of Gut Microbiota.Front Nutr. 2020 Dec 23;7:612377. doi: 10.3389/fnut.2020.612377. eCollection 2020. Front Nutr. 2020. PMID: 33425976 Free PMC article. Review.
-
Leaky Gut and Autoimmunity: An Intricate Balance in Individuals Health and the Diseased State.Int J Mol Sci. 2020 Dec 21;21(24):9770. doi: 10.3390/ijms21249770. Int J Mol Sci. 2020. PMID: 33371435 Free PMC article. Review.
-
Gluten Free Diet for the Management of Non Celiac Diseases: The Two Sides of the Coin.Healthcare (Basel). 2020 Oct 14;8(4):400. doi: 10.3390/healthcare8040400. Healthcare (Basel). 2020. PMID: 33066519 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials